Senior insider sale
Chief Executive Officer at NEWAMSTERDAM PHARMA CO N.V. — senior position signals high conviction
$27.13M
750K shares
What this filing means
DAVIDSON MICHAEL H. plans to sell 750K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $27.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2026ACC: 0001968582-26-000152
DirectorOfficer· Chief Executive Officer
Since Mar 2026
750K
Shares to sell
$27.13M
Approx. market value
750K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Option Exercise
Cash
2/24/2025
750KTotal acquired750K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2025 | Option Exercise Cash | 750K | — |
| Total | 750K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
750K
Market value
$27.13M
2/24/2026
Total
Units
750K
Value
$27.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/24/2026 | 750K | $27.13M | Nasdaq | Planned |
| Total | 750K | $27.13M | ||